Comparsion between lekhan vasti and mustadi gana vasti in treating Obesity

Evaluation of comparative efficacy of Mustadi Gana Vasti (Kala Vasti) versus Lekhana Vasti (Kala Vasti) in the management of Obesity (Sthoulya): A randomized clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094102

Enrollment

Registered

2025-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients are willing to give written informed consent 2.Patients of either sex aged between 20 and 60 years 3.A patient who is fit for Vasti 4.Primary obesity 5.The patients selected for the clinical trial were selected according to signs and symptoms of Sthoulya described in Ayurvedic texts and modern parameters 6.BMI is between 27 to 40

Exclusion criteria

Exclusion criteria: 1.Patients suffering from pulmonary disease, Cardiac diseases, Endocrine disorders, and complicated cases were not taken for the study. Patients having a BMI of more than 40 above i.e., class II, III, extremely high obesity and severe complicated cases, will be excluded. 2.Patients with uncontrolled type 2 diabetes. 3.Pregnant and lactating women. 4.Sthoulya with pregnancy and with other significant associated illnesses, patients taking corticosteroids, oral contraceptive pills. 5.Drug-induced obesity (E66.1 of ICD-10 criteria) 6.Obesity due to any secondary causes, i.e, (Endocrine causes: Hypothyroidism, Cushing?s disease), (Genetic causes: Monogenic obesity: Leptin and leptin receptor deficiency), (Syndromic obesity: Prader?Willi syndrome, Bardet-Biedl syndrome) 7.Toxicological contents are excluded from the trial group. (Semecarpus anacardium, Aconitum heterophyllum)

Design outcomes

Primary

Measure	Time frame
To assess the efficacy of Mustadi Gana Vasti over BMI, Anthropometric measures, and Lipid Profile (Blood Cholesterol level) in patients with obesity.Timepoint: 16th and 48th day	—

Secondary

Measure	Time frame
To assess the efficacy of Mustadi Gana Vasti over BMI, Anthropometric measures, and Lipid Profile (Blood Cholesterol level) in patients with obesity.Timepoint: 16th and 48th day	—

Countries

India

Contacts

Public ContactDR ADESH KRUSHNAKANT PANDAV

Mahatma Gandhi Ayurved College Hospital and Research Center

shweta.parwe@dmiher.edu.in9403142270

Outcome results